Blood Warmers Market

The Blood Warmers Market is valued at USD 251.6 Mn in 2026 and is projected to reach USD 413.3 Mn,  growing at a CAGR of 6% by 2033.

In 2021, the blood warmers market displayed stable growth and per industry figures, it stood at around US$900 Mn in terms of value. According to a preliminary study carried out by Fairfield Market Research, the market is expected to continue to grow at healthy rate over 8% through 2030. The market refers to the market for devices and equipment used to warm blood products before they are administered to patients during medical procedures. North America is the largest market for blood warmers, followed by Europe, and the Asia Pacific. This global market is expected to continue to grow in the coming years, driven by technological advancements, increasing adoption of portable blood warmers, and rising awareness of the benefits of blood warmers among healthcare professionals.

• Market revenue hit the US$900 Mn mark in 2021
• Increasing surgical procedures to fuel the use of blood warmers in medical facilities and surgical centres
• Growing demand for intravenous blood warmers to significantly contribute to market growth
• North America to cement its dominance in the blood warmers market
• New launches and collaborations among key players remain preferred growth strategies

Increasing Number of Surgeries, and Trauma Cases

The exponential increase in the number of trauma cases and surgeries worldwide continue to remain instrumental in driving the growth trajectory of the blood warmers market. A surging volume of these surgeries are often related to the adoption of dialysis solutions in various stages of disease complexity. For instance, according to a report by the American Kidney Fund 2022, more than 37 million individuals in the United States suffer from kidney diseases, and as of 2021, approximately 810,000 individuals in this country suffer from kidney failure. This has triggered a spike in the use of dialysis machines which in turn have driven the demand for blood warming devices.

Furthermore, road traffic injuries are one of the main causes of death worldwide. For instance, according to the World Health Organization (WHO), injuries due to road traffic accidents are projected to be the 9^th leading cause of deaths on a global scale. In addition, accidental injuries requiring surgical procedures can cause hypothermia. This has fuelled the use of blood warmers in surgical procedures to maintain a patient’s body temperature. This is more likely to result in improved patient outcomes, thus bolstering blood warmers market growth.

Growing Demand for IV Systems

As the use of blood warmers for intra-operative infusions continues to increase, the need for intravenous systems is also expected to soar at a rapid rate. This is primarily owed to the ability of intravenous systems to reduce the probability of unintended peri-operative hypothermia conditions during surgical procedures. That said, the demand for intravenous blood warmers is expected to grow at a considerable rate in the coming years.

In addition, rising volumes of surgical procedures backed by the increasing prevalence of chronic ailments affecting kidney health continue to influence the use of intravenous systems. In this backdrop, the growing demand for intravenous blood and fluid warmers is poised to largely contribute towards the growth of the global blood warmers market.

Growth Challenges

High Device Costs, Stringent Regulations, and Availability of Alternatives

Blood warming devices are expensive, and this may hinder their adoption, particularly in countries with limited healthcare budgets. Moreover, these devices are subject to strict regulatory guidelines and approvals, which could prove to be a tedious and time-consuming endeavour, not to mention the cost factor again. Additionally, the presence of alternative solutions to blood warmer devices such as warm water baths, etc., may also limit device adoption. Factors such as these are expected to have a negative influence on the global blood warmers market in the years ahead.

North America Reigns Supreme

The blood warmers market in North America is expected to index momentous growth in the coming years. This can be attributed to rising healthcare expenditures coupled with other macroeconomic factors such as strong economic growth and a rising GDP per capita. Among other countries, the United States is projected to cement its dominance in North America. Each year, the US government spends a considerable parentage of the country’s GDP on healthcare. According to a report by the Organization of Economic Co-operation and Development (OECD), approximately 17% of the US GDP was spent on healthcare in 2020. This is likely to pave a potential pathway of lucrative opportunities for the market here.

Moreover, the rising number of surgical procedures and the increasing prevalence of various chronic ailments are other elements influencing the growth trajectory of the blood warmers market in North America. Additionally, the volume of emergency department visits remains high. For instance, according to a 2021 report by the Centre for Disease Control and Prevention (CDC), emergency department visits in the United States that resulted in hospital admissions crossed over 16 million. Of these, around 2.3 million required admissions to critical care units. Such emergency critical cases often need effective emergency transfusions to prevent hypothermia among patients. This factor remains instrumental in driving the demand for blood warmers in hospitals as well as other surgical facilities and centres.

Furthermore, the number of premature births in the United States were high in comparison to other developed economies across North America, and Europe. For instance, according to the Centre of Disease Control and Prevention, of 10 infants, one birth is premature every year. This has fuelled the volume of blood transfusions, in turn pushing the demand for blood warmers in the country. That said, North America is expected to continue accounting for a significant share of the blood warmers market.

Some of the major players in the market include 

• 3M Company
• Smiths Medical (ICU Medical)
• Baxter International Inc.
• BD (Becton, Dickinson and Company)
• Fresenius Kabi AG
• Stryker Corporation
• Belmont Instrument Corporation
• The 37Company (37°C Medical)
• Vyaire Medical, Inc.
• MEQU A/S
• Geratherm Medical AG
• Sarstedt AG & Co. KG
• Emit Corporation
• Kandymed (QinFlow)
• Biolight Meditech Co., Ltd.

Key Developments:

• In January 2022, Premier Inc. and QinFlow Inc. were offered a group purchasing agreement for blood and fluid warmers. With this agreement, healthcare organizations would gain access to next-generation blood warming tech that is fine tuned to comply with the strict regulations and norms of intensive care units, emergency departments, trauma bays and operating rooms
• In May 2022, LifeWarmer launched a Quantum Blood and Fluid Warming System. This new product is a key development revolutionizing the blood warmers space
• In April 2021, MEQU introduced M Station, an in-hospital solution for M Warmer Systems, its IV fluid and blood warming device
• In July 2021, MEQU gained a public tender to supply portable blood warmers and IV fluid warming devices (the M Warmer) in partnership with Fenton Pharmaceuticals to the Ministry of Defence

By Device Type

• System (Water Bath Warmers, Dry Heat Plate Warmers, and IV-Fluid Tube Warmers)
• Consumables

By Flowability

• Fast Flow Warmers
• Standard Flow blood Warmers

By Application

• Surgical Procedures
• Blood Transfusions
• Others

By End User

• Hospitals and ASCs
• Specialty Clinics
• Blood Banks and Transfusion Centers
• Others

By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa